Trader: Low Volume ...
Arqule Inc. (ARQL: NASDAQ)
$5.68 0.15 | 2.71%
06/04/12 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| ARQL | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -21.56 | -17.59 | 9.29 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 61.90 | 2.35 | 0.49 |
| Net Income | -0.79 | 0.00 | |
| EPS | -0.83 | 0.00 |
Earnings for ARQL:
| EBITDA | -9.00 |
| REVENUE | 47.31M |
Average Earnings Estimates
| Qtr (06/12) | Qtr (09/12) | FY (12/12) | FY (12/13) | |
|---|---|---|---|---|
| Average Estimate | $-0.07 | $-0.09 | $-0.32 | $-0.58 |
| Number of Analysts | 5 | 5 | 4 | 5 |
| High Estimate | $-0.04 | $-0.06 | $-0.27 | $-0.36 |
| Low Estimate | $-0.11 | $-0.14 | $-0.38 | $-0.94 |
| Prior Year | $-0.20 | $-0.04 | $-0.20 | $-0.32 |
| Growth Rate (Year over Year) | 66.00% | -125.00% | -57.50% | -82.86% |
Portfolios with ARQL
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- UserGFNN Stockdiagnostics 11
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- UserASCO 2010
- UserDano Boy's List
- User2bullmates Portfolio 1
- UserASCO 2009 Part 2 the end of...
- UserBVF Inc.
- UserASCO is coming...Papers rel...
Latest ARQL Headlines from TheStreet
- ASCO 2012 Live Blog -- Saturday 06.02.12 | 07:06 am
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- ASCO '12 Abstract Dump: Cancer Stocks in Focus (Update) 05.17.12 | 06:05 am
- ASCO '12 Abstract Dump: Cancer Stocks in Focus 05.16.12 | 06:05 pm
- 3 Stocks Under $10 Moving Higher 04.03.12 | 12:04 pm
- 7 Cancer Drug Stocks to Know Right Now 03.14.12 | 09:03 am
- Arqule Inc. Stock Downgraded (ARQL) 11.15.11 | 06:11 am
- Arqule Inc. Stock Upgraded (ARQL) 05.10.11 | 07:05 am
- Stocks Under $10: Soaring Biotech Stock
01.19.11 | 08:01 am - Crystallex International, Sprint Nextel: Early Volume Plays 06.07.10 | 08:06 am
Press Releases for ARQL
- Positive Phase 2 Study Results For Tivantinib In Previously Treated Hepatocellular Carcinoma To Be Presented At ASCO - Business Wire 06.02.12 | 07:06 am
- ArQule, Inc. To Present At Jefferies 2012 Global Healthcare Conferences - Business Wire 05.31.12 | 08:05 am
- ArQule And Daiichi Sankyo Announce Completion Of Patient Recruitment In Phase 3 Clinical Trial Of Tivantinib In Non-Small Cell Lung Cancer - Business Wire 05.18.12 | 07:05 am
- Positive Phase 2 Clinical Data With Tivantinib In Hepatocellular Carcinoma To Be Highlighted In Oral Presentation At 2012 Annual Meeting Of American Society Of Clinical Oncology - Business Wire 05.17.12 | 07:05 am
- ArQule Reports First Quarter 2012 Financial Results - Business Wire 05.03.12 | 07:05 am
- ArQule To Report First Quarter 2012 Financial Results On May 3, 2012 - Business Wire 04.26.12 | 08:04 am
- ArQule Announces Completion Of Common Stock Offering With Full Exercise Of Option To Purchase Additional Shares - Business Wire 04.16.12 | 04:04 pm
- ArQule Prices Public Offering Of Common Stock - Business Wire 04.11.12 | 07:04 am
- ArQule Announces Proposed Public Offering - Business Wire 04.10.12 | 07:04 am
- ArQule Announces Presentations At AACR 102nd Annual Meeting - Business Wire 03.29.12 | 08:03 am
Partner Headlines for ARQL
- Stock Insights: Dendreon, Medtronic, FedEx, ArQule, Rentrak June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- ArQule Announces Positive Phase 2 Study Results for Tivantinib in Previously Treated Hepatocellular Carcinoma - Benzinga 06.02.12 | 06:06 pm
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 05.01.12 | 09:05 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 04.02.12 | 09:04 am
- Company News for January 18, 2012 - Corporate Summary - Zacks 01.18.12 | 10:01 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.15.11 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 10.04.11 | 09:10 am
- Drugs to Watch at ASCO 2011 - Seeking Alpha 06.02.11 | 08:06 am
- Future Biotech Superstars - Seeking Alpha 03.30.11 | 09:03 am





